87 related articles for article (PubMed ID: 2613357)
1. The production of platelet-activating factor during hemodialysis.
Tetta C; Segoloni G; Pacitti A; Regis G; Salomone M; Turello E; Camussi G; Vercellone A
Int J Artif Organs; 1989 Dec; 12(12):766-72. PubMed ID: 2613357
[TBL] [Abstract][Full Text] [Related]
2. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
Iatrou C; Afentakis N; Nomikos T; Dinas C; Stavropoulos-Giokas C; Antonopoulou S
Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
[TBL] [Abstract][Full Text] [Related]
3. Platelet-neutrophil interactions during hemodialysis: a proposed biocompatibility approach.
Stuard S; Bonomini M; Settefrati N; Albertazzi A
Int J Artif Organs; 1998 Feb; 21(2):75-82. PubMed ID: 9569128
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms and kinetics of the synthesis and release of platelet-activating factor (PAF) by polyacrylonitrile membranes.
Guastoni C; Tetta C; Hoenich NA; Gervasio R; Sereni L; Tessore E; Wratten ML; Civati G
Clin Nephrol; 1996 Aug; 46(2):132-8. PubMed ID: 8869791
[TBL] [Abstract][Full Text] [Related]
5. In vitro complement-independent activation of human neutrophils by hemodialysis membranes: role of the net electric charge.
Tetta C; Segoloni G; Camussi G; Neumann S; Griva S; Piva S; Pacitti A; Vercellone A
Int J Artif Organs; 1987 Mar; 10(2):83-8. PubMed ID: 3583432
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
Germin Petrović D
Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
[TBL] [Abstract][Full Text] [Related]
8. Endothelin and platelet activating factor. Possible indices for biocompatibility of hemodialysis.
Akizawa T; Kinugasa E; Koshikawa S
ASAIO Trans; 1991; 37(3):M384-5. PubMed ID: 1751199
[TBL] [Abstract][Full Text] [Related]
9. The production of platelet-activating factor (PAF) during hemodialysis with cuprophane membrane. Does the calcium concentration in the dialysate play any role on it?
Iatrou C; Afentakis N; Antonopoulou S; Andrikopoulos N; Demopoulos CA; Ziroyannis P
Int J Artif Organs; 1995 Jul; 18(7):355-61. PubMed ID: 8655220
[TBL] [Abstract][Full Text] [Related]
10. Mediators of complement-independent granulocyte activation during haemodialysis: role of calcium, prostaglandins and leukotrienes.
Böhler J; Donauer J; Birmelin M; Schollmeyer PJ; Hörl WH
Nephrol Dial Transplant; 1993; 8(12):1359-65. PubMed ID: 8159305
[TBL] [Abstract][Full Text] [Related]
11. Biocompatibility of different hemodialysis membranes: activation of complement and leukopenia.
Wegmüller E; Montandon A; Nydegger U; Descoeudres C
Int J Artif Organs; 1986 Mar; 9(2):85-92. PubMed ID: 3699914
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil behavior during hemodialysis. Role of membrane contact.
Neveceral P; Markert M; Wauters JP
ASAIO Trans; 1988; 34(3):564-7. PubMed ID: 2848563
[TBL] [Abstract][Full Text] [Related]
13. Increases in circulating level of platelet-activating factor lag behind transient neutropenia during hemodialysis with cuprophane membranes.
Sakaguchi K; Morimoto S; Chen YH; Nakamoto Y; Ogihara T
Nephron; 1991; 59(3):455-60. PubMed ID: 1758537
[TBL] [Abstract][Full Text] [Related]
14. A comparison of dialysers with low-flux membranes: significant differences in spite of many similarities.
Ward RA; Buscaroli A; Schmidt B; Stefoni S; Gurland HJ; Klinkmann H
Nephrol Dial Transplant; 1997 May; 12(5):965-72. PubMed ID: 9175051
[TBL] [Abstract][Full Text] [Related]
15. Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis.
Sirolli V; Di Stante S; Stuard S; Di Liberato L; Amoroso L; Cappelli P; Bonomini M
Int J Artif Organs; 2000 Jun; 23(6):356-64. PubMed ID: 10919752
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte activation during hemodialysis.
Hörl WH; Riegel W; Steinhauer HB; Wanner C; Thaiss F; Bozkurt F; Haag M; Schollmeyer P
Clin Nephrol; 1986; 26 Suppl 1():S30-4. PubMed ID: 3829465
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of a new high-flux cellulose acetate membrane.
Schaefer RM; Huber L; Gilge U; Bausewein K; Vienken J; Heidland A
Int J Artif Organs; 1989 Feb; 12(2):85-90. PubMed ID: 2651325
[TBL] [Abstract][Full Text] [Related]
18. Role of platelet activating factor in hemodialysis.
Tetta C; David S; Biancone L; Canino F; Cambi V; Camussi G
Kidney Int Suppl; 1993 Jan; 39():S154-7. PubMed ID: 8468919
[TBL] [Abstract][Full Text] [Related]
19. Production of platelet activating factor by human neutrophils after backfiltration of endotoxin contaminated dialysate.
David S; Tetta C; Canino F; Gervasio R; Cambi V
ASAIO J; 1993; 39(3):M773-7. PubMed ID: 8268642
[TBL] [Abstract][Full Text] [Related]
20. Albumin treatment reduces in vitro platelet deposition to PMMA dialysis membrane.
Remuzzi A; Boccardo P
Int J Artif Organs; 1993 Mar; 16(3):128-31. PubMed ID: 8314634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
